General analysis, which included data from all the studies (1398 GC patients and 1588 controls), failed to show any association between CD14 -260 C/T and the risk of GC (pooled OR: 0.93 95% CI: 0.76–1.13). The gene discussed is CD14; the disease is gastric cancer.